James M. Daly, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 30,940 shares at $348.94 ($10.8M) on 2025-02-27, disclosed to the SEC on 2025-02-28.
Open-market sale of $10.8M MDGL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $346.90 | 398 | $138K | 1.3% |
| 2 | $346.90 | 398 | $138K | 1.3% |
| 3 | $347.39 | 14,302 | $5.0M | 46.2% |
| 4 | $347.39 | 14,302 | $5.0M | 46.2% |
| 5 | $348.94 | 770 | $269K | 2.5% |
| 6 | $348.94 | 770 |
| $269K |
| 2.5% |
| Total | $347.45 avg | 30,940 | $10.8M | 100% |
| Filing → |
| HALO | SELL | 2023-08-15 | $875K | — | Filing → |
| HALO | SELL | 2020-11-25 | $838K | — | Filing → |
| HALO | SELL | 2020-08-13 | $2.0M | — | Filing → |